These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33599311)

  • 41. Simple and Accurate Quantitative Analysis of 16 Antipsychotics and Antidepressants in Human Plasma by Ultrafast High-Performance Liquid Chromatography/Tandem Mass Spectrometry.
    Wang J; Huang H; Yao Q; Lu Y; Zheng Q; Cheng Y; Xu X; Zhou Q; Wu D; Zhang M; Li X; Zhang J
    Ther Drug Monit; 2015 Oct; 37(5):649-60. PubMed ID: 26384040
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation Between Serum Concentrations of N-Desmethylclozapine and Granulocyte Levels in Patients with Schizophrenia: A Retrospective Observational Study.
    Smith RL; Haslemo T; Andreassen OA; Eliasson E; Dahl ML; Spigset O; Molden E
    CNS Drugs; 2017 Nov; 31(11):991-997. PubMed ID: 28948574
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Simultaneous quantification of cyclophosphamide, 4-hydroxycyclophosphamide, N,N',N"-triethylenethiophosphoramide (thiotepa) and N,N',N"-triethylenephosphoramide (tepa) in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
    de Jonge ME; van Dam SM; Hillebrand MJ; Rosing H; Huitema AD; Rodenhuis S; Beijnen JH
    J Mass Spectrom; 2004 Mar; 39(3):262-71. PubMed ID: 15039933
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ultra-fast LC-MS/MS in therapeutic drug monitoring: Quantification of clozapine and norclozapine in human plasma.
    Couchman L; Fisher DS; Subramaniam K; Handley SA; Boughtflower RJ; Benton CM; Flanagan RJ
    Drug Test Anal; 2018 Feb; 10(2):323-329. PubMed ID: 28585411
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Validated GC/MS method for the simultaneous determination of clozapine and norclozapine in human plasma. Application in psychiatric patients under clozapine treatment.
    Vardakou I; Dona A; Pistos C; Alevisopoulos G; Athanaselis S; Maravelias C; Spiliopoulou C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Sep; 878(25):2327-32. PubMed ID: 20674521
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Automated Analysis of Clozapine and Norclozapine in Human Plasma Using Novel Extraction Plate Technology and Flow-Injection Tandem Mass Spectrometry.
    Couchman L; Subramaniam K; Fisher DS; Belsey SL; Handley SA; Flanagan RJ
    Ther Drug Monit; 2016 Feb; 38(1):42-9. PubMed ID: 26349082
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Determination of clozapine, and its metabolites, N-desmethylclozapine and clozapine N-oxide in dog plasma using high-performance liquid chromatography.
    Mosier KE; Song J; McKay G; Hubbard JW; Fang J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jan; 783(2):377-82. PubMed ID: 12482480
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Determination of clozapine in serum by radioreceptor assay versus high-performance liquid chromatography: possible detection of hydroxy-metabolites.
    Odou P; Frimat B; Fontaine B; Luyckx M; Brunet C; Robert H; Dine T; Gressier B; Cazin M; Cazin JC
    J Clin Pharm Ther; 1996 Oct; 21(5):337-42. PubMed ID: 9119916
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Screening, library-assisted identification and validated quantification of fifteen neuroleptics and three of their metabolites in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization.
    Kratzsch C; Peters FT; Kraemer T; Weber AA; Maurer HH
    J Mass Spectrom; 2003 Mar; 38(3):283-95. PubMed ID: 12644990
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetic interactions between clozapine and valproic acid in patients with treatment-resistant schizophrenia: Does UGT polymorphism affect these drug interactions?
    Sangüesa E; Cirujeda C; Concha J; Padilla PP; García CB; Ribate MP
    Chem Biol Interact; 2022 Sep; 364():110042. PubMed ID: 35853541
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI) method for simultaneous determination of venlafaxine and its three metabolites in human plasma.
    Liu W; Cai HL; Li HD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):405-11. PubMed ID: 17222591
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High throughput identification and quantification of 16 antipsychotics and 8 major metabolites in serum using ultra-high performance liquid chromatography-tandem mass spectrometry.
    Patteet L; Maudens KE; Sabbe B; Morrens M; De Doncker M; Neels H
    Clin Chim Acta; 2014 Feb; 429():51-8. PubMed ID: 24291056
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Investigation of Clozapine and Olanzapine Reactive Metabolite Formation and Protein Binding by Liquid Chromatography-Tandem Mass Spectrometry.
    Geib T; Thulasingam M; Haeggström JZ; Sleno L
    Chem Res Toxicol; 2020 Sep; 33(9):2420-2431. PubMed ID: 32786547
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Simultaneous quantification of erlotinib, gefitinib, and imatinib in human plasma by liquid chromatography tandem mass spectrometry.
    Chahbouni A; den Burger JC; Vos RM; Sinjewel A; Wilhelm AJ
    Ther Drug Monit; 2009 Dec; 31(6):683-7. PubMed ID: 19865001
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fully validated method for rapid and simultaneous measurement of six antiepileptic drugs in serum and plasma using ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometry.
    Kuhn J; Knabbe C
    Talanta; 2013 Jun; 110():71-80. PubMed ID: 23618178
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clozapine pharmacokinetics in children and adolescents with childhood-onset schizophrenia.
    Frazier JA; Cohen LG; Jacobsen L; Grothe D; Flood J; Baldessarini RJ; Piscitelli S; Kim GS; Rapoport JL
    J Clin Psychopharmacol; 2003 Feb; 23(1):87-91. PubMed ID: 12544379
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of treatment duration on plasma levels of clozapine and N-desmethylclozapine in men and women.
    Fabrazzo M; Esposito G; Fusco R; Maj M
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):197-200. PubMed ID: 8935816
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Associations between plasma clozapine/N-desmethylclozapine ratio, insulin resistance and cognitive performance in patients with co-morbid obesity and ultra-treatment resistant schizophrenia.
    Costa-Dookhan KA; Rajji TK; Tran VN; Bowden S; Mueller DJ; Remington GJ; Agarwal SM; Hahn MK
    Sci Rep; 2021 Jan; 11(1):2004. PubMed ID: 33479273
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantification of lurasidone, an atypical antipsychotic drug, in rat plasma with high-performance liquid chromatography with tandem mass spectrometry.
    Koo TS; Kim SJ; Lee J; Ha DJ; Baek M; Moon H
    Biomed Chromatogr; 2011 Dec; 25(12):1389-94. PubMed ID: 21387355
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dried Blood Spot (DBS) as a useful tool to improve clozapine, aripiprazole and paliperidone treatment: From adherence to efficiency.
    Bernardo M; Mezquida G; Ferré P; Cabrera B; Torra M; Lizana AM; Brunet M
    Rev Psiquiatr Salud Ment (Engl Ed); 2022; 15(4):230-237. PubMed ID: 36513399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.